Last $2.09 USD
Change Today -0.05 / -2.34%
Volume 34.3K
As of 1:22 PM 07/30/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Wayne T. Hockmeyer Ph.D.

Chairman of The Board, Chairman of Compensation Committee and Member of Nominating and Corporate Governance Committee, GenVec, Inc.
AgeTotal Calculated CompensationThis person is connected to 67 board members in 6 different organizations across 14 different industries.

See Board Relationships


Dr. Wayne T. Hockmeyer, Ph.D., served as the President of MedImmune Ventures Inc., a wholly-owned subsidiary of MedImmune Inc. from 2002 to June 1, 2007. Dr. Hockmeyer founded MedImmune, Inc. in April 1988 and served as its President and Chief Executive Officer from April 1988 to October 2000. From 1986 to 1988, he served as a Vice President of Research and Development at Praxis Biologics Inc. He was also employed at QIAGEN Gaithersburg, Inc. He has been Chairman of ...

Read Full Background

Corporate Headquarters*

910 Clopper Road
Gaithersburg, Maryland 20878

United States

Phone: 240-632-0740
Fax: 240-632-0735

Board Members Memberships*

Former Director
Chairman of The Board, Chairman of Compensation Committee and Member of Nominating and Corporate Governance Committee
Former Director
Former Lead Independent Director, Chairman of Compensation Committee and Member of Executive Committee
Former Director
Chairman, Member of Audit Committee, Member of Nominating Committee and Member of Corporate Governance Committee
Director, Chairman of Compensation Committee and Member of Nominating & Corporate Governance Committee
Former Director, Member of Audit Committee and Member of Compensation Committee
Former Director
Former Director
Director, Chairman of Science & Technology Committee and Member of Finance Committee


ScD 2002
Purdue University
BS 1966
Purdue University
PhD 1972
University of Florida

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

Exercisable Options27,000
Unexercisable Options75,000
Total Number of Options102,000

Total Compensation*

Total Annual Cash Compensation$88,500
Total Calculated Compensation$108,450
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GNVC:US $2.09 USD -0.05


Vijay B. Samant Chief Executive Officer, President, Acting Chief Financial Officer and Director
Vical Incorporated
Mark R. Baker J.D.Chief Executive Officer, Director and Member of Science & Strategy Committee
Progenics Pharmaceuticals, Inc.
Daniel J. O’Connor Esq.Chief Executive Officer, President and Director
Advaxis, Inc.
Jonathan J. Lewis M.D., Ph.D.Chief Executive Officer and Director
ZIOPHARM Oncology, Inc.
William D. Clark Chief Executive Officer, President and Director
Genocea Biosciences, Inc.
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GENVEC INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at